Therapeutic Effect of Oncolytic Herpes Simplex Virus Type 1 (G47Δ) in Combination with Chemotherapy on Colorectal Cancer

被引：1
|
作者：
Abe, Shinya [1 ]
Ino, Yasushi [1 ]
Fukuhara, Hiroshi [2 ]
Iwai, Miwako [1 ]
Watanabe, Toshiaki [3 ]
Todo, Tomoki [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Tokyo, Japan
[3] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33472-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
664
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [1] Oncolytic Virus Therapy for Lung Cancers Using a Genetically Engineered Oncolytic Herpes Simplex Virus Type 1 G47Δ
    Sakata, Yoshinori
    Ino, Yasushi
    Todo, Tomoki
    Ikeda, Norihiko
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S482 - S482
  • [2] An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer
    Zeng, Wei-Gen
    Li, Jun-Jie
    Hu, Pan
    Lei, Lan
    Wang, Jia-Ni
    Liu, Ren-Bin
    ONCOLOGY REPORTS, 2013, 29 (06) : 2355 - 2361
  • [3] Intracarotid delivery of oncolytic herpes simplex virus-1 G47Δ to metastatic breast cancer in the brain
    Liu, RB
    Martuza, RL
    Rabkin, SD
    MOLECULAR THERAPY, 2004, 9 : S302 - S303
  • [4] Oncolytic Herpes Simplex Virus Vector G47Δ Effectively Targets Breast Cancer Stem Cells
    Liu, R.
    Zeng, W.
    Hu, P.
    Wu, J.
    Li, J.
    Wang, J.
    Lei, L.
    CANCER RESEARCH, 2012, 72
  • [5] Oncolytic herpes simplex virus vector G47Δ in combination with androgen ablation for the treatment of human prostate adenocarcinoma
    Fukuhara, H
    Martuza, RL
    Rabkin, SD
    Ito, Y
    Todo, T
    CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7886 - 7890
  • [6] Combining oncolytic herpes simplex virus and chemotherapy: G47 and temozolomide synergize in killing glioma stem cells
    Kanai, Ryuichi
    Wakimoto, Hiroaki
    Martuza, Robert L.
    Rabkin, Samuel D.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] The oncolytic herpes simplex virus vector G47Δ effectively targets breast cancer stem cells
    Zeng, Weigen
    Hu, Pan
    Wu, Juekun
    Wang, Jiani
    Li, Junjie
    Lei, Lan
    Liu, Renbin
    ONCOLOGY REPORTS, 2013, 29 (03) : 1108 - 1114
  • [8] Oncolytic Herpes Simplex Virus Type 1 (G47Δ) Enhances the Therapeutic Efficacy of an Anti-EGFR Targeted Therapy in Murine Tumor Model
    Nagatomo, Takafumi
    Ino, Yasushi
    Iwai, Miwako
    Nishino, Hiroshi
    Todo, Tomoki
    MOLECULAR THERAPY, 2018, 26 (05) : 344 - 345
  • [9] The oncolytic herpes simplex virus vector, G47Δ , effectively targets tamoxifen-resistant breast cancer cells
    Fan, Jingjing
    Jiang, Hua
    Cheng, Lin
    Liu, Renbin
    ONCOLOGY REPORTS, 2016, 35 (03) : 1741 - 1749
  • [10] COMBINED THERAPY WITH MITOMYCIN C AND ONCOLYTIC HERPES SIMPLEX VIRUS G47 IN CARCINOMA OF URINARY BLADDER
    Jiansong, W.
    Changxing, K.
    Yigang, Z.
    Haifeng, W.
    Hongyi, X.
    Delin, Y.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 189 - 189
12345